Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page
- Check5 days agoChange DetectedA site-wide NIH notice announces a website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.7%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check19 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.0 to v3.7.1. The study record details remain unchanged.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry v3.7.0 has been added to the study record history. The prior revision v3.6.6 has been removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe study's history now includes a new revision entry (v3.6.6), indicating an update to the record. The previous revision (v3.6.5) is no longer the current version.SummaryDifference0.1%

- Check81 days agoChange DetectedThe record history now shows a new revision labeled v3.6.5, replacing the previous v3.6.4 in the version list. This indicates an update to the page's revision metadata rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.